XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Sep. 30, 2020
Sep. 30, 2019
Income Statement [Abstract]        
Net sales $ 207,085 $ 205,274 $ 553,772 $ 644,110
Cost of sales 169,155 168,918 448,856 520,423
Gross profit 37,930 36,356 104,916 123,687
Selling, product development and administrative expenses 32,227 28,909 95,418 94,011
Impairment of goodwill and other long-lived assets 0 0 61,109 0
Restructuring expenses 14,984 0 14,984 0
Operating (loss) income (9,281) 7,447 (66,595) 29,676
Employee benefit plans settlement expenses 0 186 385 25,701
Interest expense 4,537 3,666 11,870 11,025
Other expense (income), net 276 (885) 106 (1,359)
(Loss) income before income taxes (14,094) 4,480 (78,956) (5,691)
Income tax (benefit) expense (2,334) 1,574 (4,944) (5,519)
Income from equity method investment (50) (98) (24) (120)
Net (loss) income $ (11,710) $ 3,004 $ (73,988) $ (52)
(Loss) earnings per share:        
Basic (USD per share) $ (0.67) $ 0.17 $ (4.26) $ (0.00)
Diluted (USD per share) $ (0.67) $ 0.17 $ (4.26) $ (0.00)
Weighted average number of common shares outstanding:        
Basic (shares) 17,384 17,270 17,364 17,264
Diluted (shares) 17,384 17,330 17,364 17,264